HK$33.86-5.15% · 3M
Moving avg
1W+2.86%
1M+3.23%
3M-3.70%
6M-6.72%
YTD-7.08%
1Y-9.90%
3Y+229.38%
5Y+31.75%
52-week range
$3.5836% of range$5.63
Company health
Value0/6
Growth5/6
Profitability6/6
Health6/6
Dividend5/6
Bull vs bear
Strengths
- Strong 37% net margin
- High return on equity (1671%)
- Revenue compounding 12% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$26.16B
Enterprise value
$20.46B
P/E ratio (TTM)
29.06x
P/S ratio (TTM)
10.90x
EV/EBITDA
27.82x
Per share & returns
EPS (TTM)
$0.12
Dividend yield
1.37%
Beta (1Y)
0.53
30-day change
+3.23%
Trading
Volume (24h)
11.67M
Previous close
HK$33.50
Shares outstanding
6.06B
About Hansoh Pharmaceutical Group Company Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
HKEX
Symbol
3692.HK
Hansoh Pharmaceutical Group Company Limited is a large-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on HKEX (China) and trade under the ticker 3692.HK.
Frequently asked questions
What is Hansoh Pharmaceutical Group Company Limited's market cap?
Hansoh Pharmaceutical Group Company Limited (3692.HK) has a market capitalization of $26.16B.
What is Hansoh Pharmaceutical Group Company Limited's P/E ratio?
Hansoh Pharmaceutical Group Company Limited trades at a price-to-earnings (P/E) ratio of 29.06.
What exchange does 3692.HK trade on?
3692.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,221.17+0.07%
$1.15T cap
Johnson & JohnsonJNJ
$261.41+0.21%
$629.97B cap
AbbVie Inc.ABBV
$250.64+0.75%
$442.82B cap
UnitedHealth Group IncorporatedUNH
$403.30-0.56%
$366.25B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$355.30B cap
Merck & Co., Inc.MRK
$134.71+1.34%
$332.70B cap
Novartis AGSWX: NOVN
CHF 123.96-0.19%
$290.28B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.27B cap